5 results  1 of 1 

1 Clinicopathological characteristics of BRCA-associated breast cancer in Asian patients
Eun-Kyu Kim, So Yeon Park, Sung-Won Kim
J Pathol Transl Med.2020;54(4):265-275.   Published online 2020 May 14     DOI: http://dx.doi.org/10.4132/jptm.2020.04.07
      
2 Contralateral Breast Cancer and Ipsilateral Breast Tumor Recurrence in BRCA1/2 Carriers and Non-Carriers at High-Risk of Hereditary Breast Cancer
Kyung-Hwak Yoon, Sumin Chae, Eunyoung Kang, Hee-Chul Shin, Jee Hyun Kim, In Ah Kim, So Yeon Park, Sung-Won Kim, Eun-Kyu Kim
J Breast Cancer.2019;22(4):587-598.   Published online 2019 September 30     DOI: http://dx.doi.org/10.4048/jbc.2019.22.e47
      
3 Maintenance of pegylated liposomal doxorubicin/carboplatin in patients with advanced ovarian cancer: randomized study of an Asian Gynecologic Oncology Group
Chyong-Huey Lai, Elizabeth Vallikad, Hao Lin, Lan-Yan Yang, Shih-Ming Jung, Hsueh-Erh Liu, Yu-Che Ou, Hung-Hsueh Chou, Cheng-Tao Lin, Huei-Jean Huang, Kuan-Gen Huang, Jiantai Qiu, Yao-Ching Hung, Tzu-I Wu, Wei-Yang Chang, Kien-Thiam Tan, Chiao-Yun Lin, Angel Chao, Chee-Jen Chang
J Gynecol Oncol.2020;31(1):e5.  Published online 2019 July 26     DOI: http://dx.doi.org/10.3802/jgo.2020.31.e5
      
4 BRCA1 and Breast Cancer: a Review of the Underlying Mechanisms Resulting in the Tissue-Specific Tumorigenesis in Mutation Carriers
Lukas Semmler, Cara Reiter-Brennan, Andreas Klein
J Breast Cancer.2019;22(1):1-14.   Published online 2019 January 22     DOI: http://dx.doi.org/10.4048/jbc.2019.22.e6
      
5 Prevalence of BRCA1 and BRCA2 Mutations in Korean Breast Cancer Patients
Sei Hyun Ahn, Ui Kang Hwang, Beom Seok Kwak, Ho Sung Yoon, Bo Kyung Ku, Hee Jun Kang, Ji Su Kim, Byung Kyun Ko, Chang Dae Ko, Kyung Sik Yoon, Dae-Yeon Cho, Jun Suk Kim, Byung Ho Son
J Korean Med Sci.2004;19(2):269-274.   Published online 2004 April 30     DOI: http://dx.doi.org/10.3346/jkms.2004.19.2.269
      

 1 of 1